Maximum quantity allowed is 999
Please select the quantity
CAS RN: 104-06-3 | Product Number: T3632
Thiacetazone
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- (4-Acetylamino)benzaldehyde Thiosemicarbazone
- N-[4-[(2-Carbamothioylhydrazono)methyl]phenyl]acetamide
Product Documents:
| Size | Unit Price | Shanghai | Tianjin | Japan* |
|---|---|---|---|---|
| 250MG |
¥445.00
|
2 | 1 | 7 |
* For order or inquiry, please contact
Our Authorized Distributors.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
| Product Number | T3632 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__0H__1__2N__4OS = 236.29 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Packaging and Container | 250MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 104-06-3 |
| Reaxys Registry Number | 2810335 |
| PubChem Substance ID | 354335296 |
| MDL Number | MFCD00022157 |
Specifications
| Appearance | White to Orange to Green powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Elemental analysis(Nitrogen) | 22.50 to 24.50 % |
Properties (reference)
| Melting Point | 223 °C |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
| RTECS# | AE3850000 |
Transport Information:
| Customs Control Conditions (Q) |
Application
Thiacetazone: A Bacteriostatic Antitubercular Agent
Thiacetazone has been used as an antitubercular agent since the 1960s. Reportedly, thiacetazone is a prodrug that is oxidatively converted to their active forms by the flavin monooxygenase EtaA of Mycobacterium tuberculosis. Thiacetazone is bacteriostatic in action against tuberculosis through the inhibition of mycolic acid biosynthesis. Because the activity of thiacetazone is weak, it is usually used as a combination with first-line tuberculosis medications, such as isoniazid [I0138] and rifampicin [R0079]. (The product is for research purpose only.)
References
- Oxidative Activation of Thiacetazone by the Mycobacterium tuberculosis Flavin Monooxygenase EtaA and Human FMO1 and FMO3
- A common mechanism of inhibition of the Mycobacterium tuberculosis mycolic acid biosynthetic pathway by isoxyl and thiacetazone
- Bioactivation of antituberculosis thioamide and thiourea prodrugs by bacterial and mammalian flavin monooxygenases (a review)
- Antituberculosis agents (a review)
- Isocratic high-performance liquid chromatographic determination of thiacetazone by direct injection of plasma into an internal surface reversed-phase column
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.